Concepedia

Mahila Ferrari

MF

Statistics

Publications

53

Citations

3.7K

H-Index

31

Active since

1999

Affiliations

European Institute of Oncology(Current)

Ripamonti

Istituti di Ricovero e Cura a Carattere Scientifico

University of Milan

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

Mahila Ferrari is an author at European Institute of Oncology specializing in medicine, nuclear medicine, and oncology.

ORCID

Publications per year

1999–2025

53

Publications

53

Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors

Lisa Bodei, Marta Cremonesi, Mahila Ferrari et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2008 · 424 citations

, , +17

Peptide receptor radionuclide therapy with 177Lu-DOTATATE: the IEO phase I-II study

Lisa Bodei, Marta Cremonesi, Chiara Maria Grana et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2011 · 421 citations

, , +14

Safety of sentinel node biopsy in pregnant patients with breast cancer

Oreste ­Gentilini, Marta Cremonesi, Giuseppe Trifirò et al. · Annals of Oncology · 2004 · 230 citations · Full text

, , +15

Dosimetry in Peptide radionuclide receptor therapy: a review.

Marta Cremonesi, Mahila Ferrari, Lisa Bodei et al. · PubMed · 2006 · 206 citations

, , +17

Receptor-mediated radiotherapy with 90Y-DOTA-D-Phe1-Tyr3-octreotide

Giovanni Paganelli, Stefania Zoboli, Marta Cremonesi et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2001 · 205 citations

, , +12

1–5 of 53